checkAd

    EQS-Adhoc  113  0 Kommentare Eckert & Ziegler Reduces Dividend to Finance Future Investments. Earnings Growth Expected for 2024.

    Für Sie zusammengefasst
    • Eckert & Ziegler reduces dividend to fund investments.
    • Earnings growth expected for 2024.
    • Shareholders to receive additional Pentixapharm share.

    EQS-Ad-hoc: Eckert & Ziegler SE / Key word(s): Dividend
    Eckert & Ziegler Reduces Dividend to Finance Future Investments. Earnings Growth Expected for 2024.

    19-March-2024 / 19:46 CET/CEST
    Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.


    Berlin, 19 March 2024 – The Supervisory Board and Executive Board of Eckert & Ziegler (ISIN DE0005659700, TecDAX) today decided to propose to the Annual General Meeting a reduced dividend of € 0.05 per share entitled to a dividend. The liquidity thus remaining in the company will be used to finance new high-return projects in the continuously growing market for radiopharmaceuticals. This includes, in particular, the expansion of global production capacities. The dividend reduction is also intended to ensure greater independence from external financing.

    In addition to the reduced dividend, EZAG shareholders are to receive one additional Pentixapharm share for each EZAG share in the course of the planned split-off of Pentixapharm AG.

    In the 2023 financial year, the Eckert & Ziegler Group increased sales by 11% to € 246.1 million. Net profit for the year amounted to € 26.3 million corresponding to earnings per share of € 1.26.

    For the 2024 financial year, the Executive Board expects sales of just under € 265 million and EBIT from continuing operations before one-off effects of around € 50 million.

    The detailed annual financial statements for 2023 will be published on March 22, 2024.

    For enquiries please contact:
    Eckert & Ziegler SE, Karolin Riehle, Investor Relations
    Robert-Rössle-Str. 10, 13125 Berlin, Germany
    Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com 

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Eckert&Ziegler!
    Long
    43,48€
    Basispreis
    0,31
    Ask
    × 13,87
    Hebel
    Short
    48,35€
    Basispreis
    0,35
    Ask
    × 13,44
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.



    End of Inside Information

    19-March-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.eqs-news.com


    Language: English
    Company: Eckert & Ziegler SE
    Robert-Rössle-Str.10
    13125 Berlin
    Germany
    Phone: +49 30 941084-138
    Fax: +49 30 941084-0
    Internet: www.ezag.de
    ISIN: DE0005659700
    WKN: 565970
    Indices: SDAX, TecDax,
    Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
    EQS News ID: 1862489

     
    End of Announcement EQS News Service

    1862489  19-March-2024 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1862489&application_name=news&site_id=wallstreet~~~257e03b8-9cbc-48b8-b6a5-ec526abf7b8e

    Eckert & Ziegler

    -0,91 %
    +15,88 %
    +32,54 %
    +5,71 %
    -7,59 %
    -40,86 %
    +83,81 %
    +578,49 %
    +1.017,10 %
    ISIN:DE0005659700WKN:565970


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc Eckert & Ziegler Reduces Dividend to Finance Future Investments. Earnings Growth Expected for 2024. EQS-Ad-hoc: Eckert & Ziegler SE / Key word(s): Dividend Eckert & Ziegler Reduces Dividend to Finance Future Investments. Earnings Growth Expected for 2024. 19-March-2024 / 19:46 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of …

    Schreibe Deinen Kommentar

    Disclaimer